"Hoarding Monkeys" performance skyrockets, "Monkeys Grass" stock prices rise together.

On the morning of July 17th, the A-shares of Zhaoyan New Medicine soared to the daily limit, while the Hong Kong shares surged by over 10%. Due to the increase in market price of experimental monkeys combined with the natural growth value, Zhaoyan New Medicine is expected to achieve a net profit attributable to shareholders of the listed company of approximately 600 million to 900 million yuan in the first half of 2026, an increase of about 8.85 to 13.77 times year-on-year. The sharp rise in the stock price of Zhaoyan New Medicine also led to an increase in the stock prices of other "monkey grass" companies, with Kanglong Huacheng's A-shares and Hong Kong shares rising by over 8%, and Pharmaron's A-shares and Hong Kong shares also rising by over 4%.